Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.100
-0.075 (-6.38%)
Feb 10, 2026, 5:22 PM CET
Newbury Pharmaceuticals AB Employees
Newbury Pharmaceuticals AB had 8 employees as of November 30, 2025. The number of employees increased by 2 or 33.33% since the number was last reported on August 31, 2025.
Employees
8
Change
2
Growth
33.33%
Revenue / Employee
4.59M SEK
Profits / Employee
-3.22M SEK
Market Cap
33.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Nov 30, 2025 | 8 | 2 | 33.33% |
| Aug 31, 2025 | 6 | 1 | 20.00% |
| Aug 31, 2024 | 5 | 0 | - |
| Aug 31, 2023 | 5 | 1 | 25.00% |
| Aug 31, 2022 | 4 | 2 | 100.00% |
| Aug 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Orexo AB | 72 |
| EQL Pharma AB | 55 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 19 |
| Nanexa AB | 15 |
| Moberg Pharma AB | 6 |
| Enorama Pharma AB | 5 |
| Vivesto AB | 4 |